Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
QIAGEN Pushes On After Thermo Fisher Walks Away

QIAGEN Pushes On After Thermo Fisher Walks Away

In early March, Thermo Fisher Scientific Inc. (NYSE: TMO) announced a takeover QIAGEN N.V. (NYSE: QGEN) for $11.5 billion, or $43.64 per share in cash. The offer seemed high enough, as the target company only generated revenues of $1.53 billion in 2019, but the COVID-19 pandemic complicated the deal. QIAGEN saw a surge in product demand used in COVID-19 testing, as net sales grew 16% in Q2:20 over the same quarter in 2019, so its shareholders thought Thermo Fisher’s needed to up its offer. Thermo Fisher revised its offer to $49 per share on August 4, but it needed a minimum acceptance threshold of 66.67% from QIAGEN shareholders before the August 10 deadline. The new acquisition... Read More »
Vocera Adds New Patient Engagement Firm

Vocera Adds New Patient Engagement Firm

Vocera Communications, Inc. (NYSE: VCRA), a mobile technology company serving the healthcare market, has expanded its patient engagement platform through a new acquisition. Last week, Vocera purchased a 100% interest in EASE Applications, LLC for $25 million in cash. This is Vocera’s first acquisition of 2020, but the company has had a solid financial year, reporting total revenue of $47.3 million for the second quarter of 2020, compared to revenue of $44.8 million in the second quarter of 2019. Its remote communication services were probably in high demand due to changes triggered by COVID-19. The addition of EASE will most likely help them in the COVID-19 environment as well. EASE... Read More »
JNJ Announces Multibillion-Dollar Takeover of Momenta

JNJ Announces Multibillion-Dollar Takeover of Momenta

Johnson & Johnson (NYSE: JNJ) made a splash in the healthcare M&A market last week with its acquisition of Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA). The global pharmaceutical giant announced on August 19 it is paying $6.5 billion in cash, or $52.50 per share, for Momenta, a 70.4% premium over Momenta’s August 18 closing price. Momenta reported a trailing 12-month revenue of $30.07 million. On the day of the announcement, Momenta’s share price jumped 69%. This acquisition provides an opportunity for the Janssen Pharmaceutical Companies of JNJ to broaden its market reach in immune-mediated diseases and drive further growth through expansion into autoantibody-driven... Read More »
Health Care M&A Deals, August 21, 2020

Health Care M&A Deals, August 21, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Johnson & Johnson’s $6.5 billion acquisition of Momenta Pharmaceuticals, Inc., which provides an opportunity for JNJ to broaden its portfolio in immune-mediated diseases and autoantibody-driven diseases. To subscribe to our Health Care M&A deals chart and more, visit our membership... Read More »
Pinnacle Treatment Centers Adds HealthQwest

Pinnacle Treatment Centers Adds HealthQwest

Pinnacle Treatment Centers and Linden Capital Partners, L.P. began their partnership in 2016, launching a national behavioral health platform in the years since. When Pinnacle Treatment Centers was acquired by Linden Capital, it served roughly 10,000 patients daily at approximately 30 facilities, according to Deal Search Online. In 2020, the company treats 31,000 patients daily in California, Indiana, Kentucky, New Jersey, Ohio, Pennsylvania and Virginia, with over 115 community-based locations. The company has grown organically, opening new locations and facilities, but also through acquisitions with the backing of Linden Capital. In April 2019, Pinnacle acquired three outpatient opioid... Read More »
Health Care M&A Deals, August 21, 2020

Health Care M&A Deals, August 14, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Bayer AG’s $425 million acquisition of KaNDy Therapeutics Ltd., which will give Bayer KaNDy’s NT-814, a potentially first in class receptor antagonist which showed positive findings for the treatment of moderate to severe vasomotor symptoms due to menopause.  To subscribe to our Health Care M&A deals chart and more,... Read More »
MOB Deals Accelerate in the Third Quarter

MOB Deals Accelerate in the Third Quarter

Medical office building (MOB) transactions have been flowing steadily throughout the third quarter, with 11 deals on the books so far according to DSO. Most deals are focused on facilities in the Southeastern region of the United States, such as Alabama, North and South Carolina, and Georgia, and the buyers are a mix of REITs, private real estate investment firms, and developers. So far in the third quarter, over 376,000 square feet of MOBs have been sold, with disclosed prices totaling approximately $113.6 million. Unlike other sectors in healthcare, MOBs seem to have benefited from a COVID-19 environment, as noted by JLL ( NYSE: JLL) in a report published in July. The COVID-19 pandemic... Read More »
Health Catalyst Acquires Vitalware

Health Catalyst Acquires Vitalware

Health Catalyst (NASDAQ: HCAT) has been an active buyer this year. In July, the digital health firm purchased healthfinch, Inc. for $40 million to build its population health portfolio and electronic health record platform, and now it is boosting its revenue cycle management services. Health Catalyst announced last week it is acquiring Vitalware, LLC, which provides revenue workflow optimization and analytics SaaS technology solutions to healthcare organizations. The terms of the deal include $120 million upfront and an additional $30 million could be paid as a potential earnout. The upfront payment will be comprised of a mix of cash and 1,487,210 shares valued at $33.62. Vitalware offers... Read More »
Healthscope Divests Asia Pacific Healthcare Group

Healthscope Divests Asia Pacific Healthcare Group

In an effort to refocus its business plan, Healthscope is selling Asia Pacific Healthcare Group (APHG), its New Zealand pathology business. With 25 laboratories, over 2,000 staff, and 150 collection centers throughout the country, APHG performed over 6.7 million pathology patient episodes across New Zealand in 2019. The group has also been heavily involved in providing testing as part of New Zealand’s response to COVID-19. Healthscope is the second-largest private hospital operator in Australia The buyers are the New Zealand Superannuation Fund (NZ Super Fund), which invests money on behalf of the New Zealand government to help pay for the increased cost of universal pension entitlements... Read More »
IBH Population Health Expands With New Acquisition

IBH Population Health Expands With New Acquisition

IBH Population Health Solutions, a pioneer in managed behavioral health, integrated employee assistance programs (EAP) and services, announced a new acquisition this week. With the backing of Periscope Equity, the company added Claremont EAP for an undisclosed price, an agency that helps connect employees at transportation agencies, municipalities, labor groups, high tech firms, education, retail, and more with licensed mental health counselors. IBH Population Health is one of the U.S.’s leading population health management companies, providing EAP, managed behavioral health, wellness, data analytics, and opioid assessment and treatment solutions. The deal will significantly broaden... Read More »